Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 43
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Evolving policies for donors with diabetes: The Canadian experience | Miller O, Caffrey N, O'Brien SF, Goldman M | 2022 | Vox Sang | View Evolving policies for donors with diabetes: The Canadian experience | Researchers | New or improved product or process |
A data-driven approach to determine daily platelet order quantities at hospitals | Mirjalili M, Abouee-Mehrizi H, Barty R, Heddle NM, Sarhangian V | 2022 | Transfusion | View A data-driven approach to determine daily platelet order quantities at hospitals | Researchers | New or improved product or process |
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, Vitiello Teixeira G, Saraiva Pedro R, Roberto Gomes Takey P, Kegele Lignani L, Reis Xavier J, Cardoso Doria da Gama V, Amorim Filho L, Emoingt Furtado B, Santa Maria A, Dahrug Barros T, Neves Waite Freitas L, Dos Santos Pereira T, Lima Abreu D, Bernardes Ramos M, Gabe C, Arnold D, William Smith J, Nazy I, Lourdes de Sousa Maia M | 2022 | Vaccine | View Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Health care providers | Clinical research |
An evaluation of the clinical impacts of 7-day platelets | Ning S, Gabarin N, Li N, Liu Y, Lucier K, Barty R, Acker J, Webert KE, Warkentin TE, Arnold DM, Heddle NM | 2023 | Transfusion | View An evaluation of the clinical impacts of 7-day platelets | Researchers | Clinical research |
Database-driven research and big data analytic approaches in transfusion medicine | Ning S, Li N, Barty R, Arnold D, Heddle NM | 2022 | Transfusion | View Database-driven research and big data analytic approaches in transfusion medicine | Researchers | Clinical research |
KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Ning S, Morin PA, Elahie A, Li N, Liu Y, Barty R, Clarke G, Zeller M, Heddle NM | 2023 | Transfusion | View KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Health care providers | Clinical research |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Health care providers | New or improved product or process |
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Nummi V, Lehtinen AE, Iorio A, Szanto T, Lassila R | 2022 | Haemophilia | View Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Researchers | Clinical research |
RE: A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens | O'Brien S, Goldman M, Drews S | 2022 | CMAJ | View RE: A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens | Researchers | Clinical research |
Surveillance report | O'Brien SF | 2022 | Blood.ca website | View Surveillance report | Blood operators | Benchmarking and standard setting |
Rapport de surveillance | O'Brien SF | 2022 | Blood.ca website | View Rapport de surveillance | Blood operators | Benchmarking and standard setting |
Canadian blood suppliers: An expanding role in public health surveillance? | O'Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Can Commun Dis Rep | View Canadian blood suppliers: An expanding role in public health surveillance? | Health care providers | New or improved product or process |
How do we decide how representative our donors are for public health surveillance? | O'Brien SF, Drews SJ, Lewin A, Russell A, Davison K, Goldman M, International Society for Blood Transfusion Transfusion Transmitted Infectious Disease Working Party Surveillance Risk Assessment Policy Sub-group | 2022 | Transfusion | View How do we decide how representative our donors are for public health surveillance? | Researchers | Benchmarking and standard setting |
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | O’Brien SF, Caffrey N, Yi Q-L, Bolotin S, Janjua NZ, Binka M, Thanh CQ, Stein DR, Lang A, Colquhoun A, Pambrun C, Reedman CN, Drews SJ | 2023 | Microbiol Spectr | View Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | Researchers | Clinical research |
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ | 2022 | Viruses | View SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | Researchers | Clinical research |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
An expanded role for blood donor emerging pathogens surveillance | O’Brien SF, Goldman M, Drews S | 2023 | CMAJ | View An expanded role for blood donor emerging pathogens surveillance | Blood operators | New or improved product or process |
Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance | O’Brien SF, Reedman CN, Osiowy C, Bolotin S, Yi Q-L, Lourenço L, Lewin A, Binka M, Caffrey N, Drews SJ | 2023 | Viruses | View Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance | Researchers | Clinical research |
Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Okello CD, Shih AW, Angucia B, Kiwanuka N, Heddle N, Orem J, Mayanja-Kizza H | 2022 | PLoS One | View Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Health care providers | Clinical research |
Preparing small-dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation | Olafson C, William N, Howell A, Beaudin L, Gill B, Clarke G, Stephens S, Lopes-Carvalho D, Lane D, Schubert P, McTaggart K, Acker JP | 2022 | Transfusion | View Preparing small-dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation | Researchers | New or improved product or process |
Chapter 14. Therapeutic apheresis | Oliver M, Patriquin C | 2023 | Clinical Guide to Transfusion | View Chapter 14. Therapeutic apheresis | Health care providers | Benchmarking and standard setting |
Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Parmar G, Allan DS, Morris G, Dibdin N, Ganz K, Mostert K, Paulson K, Petraszko T, Stevens N, Seftel MD | 2023 | Curr Oncol | View The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Health care providers | Clinical research |
A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services’ Cord Blood Bank: First Analysis | Parmar G, Green M, Mostert K, Lawless T, Dibdin N, Weiss J, Ganz K, Petraszko T, Seftel MD, Allan DS | 2022 | Curr Oncol | View A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services’ Cord Blood Bank: First Analysis | Researchers | Benchmarking and standard setting |
Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Patterson S, Sandercock N, Verhovsek M | 2022 | Am J Hematol | View Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Health care providers | Clinical research |
NAC Statement on RHD Genotyping in Prenatal Patients | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View NAC Statement on RHD Genotyping in Prenatal Patients | Health care providers | Benchmarking and standard setting |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Peng HT, Rhind SG, Moes K, Devine D, Jenkins C, Beckett A | 2022 | Transfusion | View Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Health care providers | New or improved product or process |
How do I/we forecast tomorrows’ transfusion: Blood components | Pereyra N, Devine DV | 2023 | Transfus Clin Biol | View How do I/we forecast tomorrows’ transfusion: Blood components | Health care providers | New or improved product or process |
Massive Hemorrhage Protocol: A Practical Approach to the Bleeding Trauma Patient | Petrosoniak A, Pavenski K, da Luz LT, Callum J | 2023 | Emerg Med Clin North Am | View Massive Hemorrhage Protocol: A Practical Approach to the Bleeding Trauma Patient | Health care providers | Benchmarking and standard setting |
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Chapter 17. Troubles de l’hémostase et angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapter 17. Troubles de l’hémostase et angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Coagulation and complement: Key innate defense participants in a seamless web | Pryzdial ELG, Leatherdale A, Conway EM | 2022 | Front Immunol | View Coagulation and complement: Key innate defense participants in a seamless web | Researchers | Basic research |
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion | Qadri SM, Liu Y, Barty RL, Heddle NM, Sheffield WP | 2022 | Vox Sang | View A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion | Researchers | Clinical research |
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Qi X, Hatami S, Bozso S, Buchko M, Forgie KA, Olafson C, Khan M, Himmat S, Wang X, Nobes DS, Acker JP, Nagendran J, Freed DH | 2022 | J Heart Lung Transplant | View The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Researchers | Basic research |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada | Quinn JG, Pavenski K, Webert K, Ye S | 2023 | National Advisory Committee on Blood and Blood Products | View NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada | Health care providers | Benchmarking and standard setting |
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Reedman CN, Drews SJ, Yi Q-L, Pambrun C, O’Brien SF | 2022 | Microbiol Spectr | View Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Researchers | Clinical research |
Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies | Saiyin T, Kirkham AM, Bailey AJM, Shorr R, Pineault N, Maganti HB, Allan DS | 2023 | Transplant Cell Ther | View Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies | Researchers | Clinical research |
Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Sask KN, Thong B, Goodarzynejad N, Berry LR, Chan AKC | 2022 | Biointerphases | View Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Researchers | Basic research |
Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Schmidt M, Ramirez-Arcos S, Stiller L, McDonald C, ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2022 | Vox Sang | View Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Researchers | Benchmarking and standard setting |
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Schubert P, Culibrk B, Bhakta V, Closas T, Sheffield WP, Devine DV, McTaggart K | 2022 | Transfusion | View Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Researchers | Basic research |
GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions | Schünemann HJ, Neumann I, Hultcrantz M, Brignardello-Petersen R, Zeng L, Murad MH, Izcovich A, Morgano GP, Baldeh T, Santesso N, Cuello CG, Mbuagbaw L, Guyatt G, Wiercioch W, Piggott T, De Beer H, Vinceti M, Mathioudakis AG, Mayer MG, Mustafa R, Filippini T, Iorio A, Nieuwlaat R, Marcucci M, Coello PA, Bonovas S, Piovani D, Tomlinson G, Akl EA | 2022 | J Clin Epidemiol | View GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions | Researchers | Clinical research |
The response of a human haematopoietic cell line to trehalose-loaded liposomes and their effect on post-thaw membrane integrity | Scott KL, William N, Acker JP | 2022 | Cryobiology | View The response of a human haematopoietic cell line to trehalose-loaded liposomes and their effect on post-thaw membrane integrity | Researchers | Basic research |
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Shapiro AD, Hardesty BM, Peyvandi F, Iorio A | 2023 | Res Pract Thromb Haemost | View Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Researchers | Clinical research |
Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα | Shen C, Mackeigan DT, Shoara AA, Xu R, Bhoria P, Karakas D, Ma W, Cerenzia E, Chen Z, Hoard B, Lin L, Lei X, Zhu G, Chen P, Johnson PE, Ni H | 2023 | J Thromb Haemost | View Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα | Researchers | Basic research |
A Primer on Biostatistics | Shih AW, Li N, Montemayor C, Heddle NM | 2022 | Practical Transfusion Medicine | View A Primer on Biostatistics | Health care providers | Benchmarking and standard setting |